BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6252222)

  • 1. An unusual form of vitamin D-dependent rickets in a child: alopecia and marked end-organ hyposensitivity to biologically active vitamin D.
    Tsuchiya Y; Matsuo N; Cho H; Kumagai M; Yasaka A; Suda T; Orimo H; Shiraki M
    J Clin Endocrinol Metab; 1980 Oct; 51(4):685-90. PubMed ID: 6252222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D resistant rickets with alopecia: a form of end organ resistance to 1,25 dihydroxy vitamin D.
    Beer S; Tieder M; Kohelet D; Liberman OA; Vure E; Bar-Joseph G; Gabizon D; Borochowitz ZU; Varon M; Modai D
    Clin Endocrinol (Oxf); 1981 Apr; 14(4):395-402. PubMed ID: 6266702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D: two different clinical courses with two different cellular defects.
    Balsan S; Garabedian M; Liberman UA; Eil C; Bourdeau A; Guillozo H; Grimberg R; Le Deunff MJ; Lieberherr M; Guimbaud P; Broyer M; Marx SJ
    J Clin Endocrinol Metab; 1983 Oct; 57(4):803-11. PubMed ID: 6309886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D.
    Brooks MH; Bell NH; Love L; Stern PH; Orfei E; Queener SF; Hamstra AJ; DeLuca HF
    N Engl J Med; 1978 May; 298(18):996-9. PubMed ID: 205789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1 alpha-hydroxyvitamin D3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia.
    Takeda E; Kuroda Y; Saijo T; Naito E; Kobashi H; Yokota I; Miyao M
    Pediatrics; 1987 Jul; 80(1):97-101. PubMed ID: 3037475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unique form of osteomalacia associated with end organ refractoriness to 1,25-dihydroxyvitamin D and apparent defective synthesis of 25-hydroxyvitamin D.
    Zerwekh JE; Glass K; Jowsey J; Pak CY
    J Clin Endocrinol Metab; 1979 Aug; 49(2):171-5. PubMed ID: 313402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D and vitamin D dependency.
    Tsuchiya Y; Matsuo N; Cho H; Tsubouchi K; Kumagai M; Nishii Y; Nanjoh M; Yamamoto T
    Contrib Nephrol; 1980; 22():89-100. PubMed ID: 6967387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D-dependent rickets types I and II. Diagnosis and response to therapy.
    Silver J; Landau H; Bab I; Shvil Y; Friedlaender MM; Rubinger D; Popovtzer MM
    Isr J Med Sci; 1985 Jan; 21(1):53-6. PubMed ID: 2982764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
    Fraser D; Kooh SW; Kind HP; Holick MF; Tanaka Y; DeLuca HF
    N Engl J Med; 1973 Oct; 289(16):817-22. PubMed ID: 4357855
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets.
    Glorieux FH; Marie PJ; Pettifor JM; Delvin EE
    N Engl J Med; 1980 Oct; 303(18):1023-31. PubMed ID: 6252463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vitamin D-resistant rickets type II: apropos of 2 cases].
    Simonin G; Chabrol B; Moulene E; Bollini G; Strouc S; Mattei JF; Giraud F
    Pediatrie; 1992; 47(12):817-20. PubMed ID: 1338926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D metabolites in serum from hypoparathyroid patients treated with vitamin D2 and 1 alpha-hydroxyvitamin D3.
    Aksnes L; Aarskog D
    J Clin Endocrinol Metab; 1980 Oct; 51(4):823-9. PubMed ID: 6968318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supranormal 25-hydroxyvitamin D and subnormal 1,25-dihydroxyvitamin D: their role in X-linked hypophosphatemic rickets.
    Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF
    Am J Dis Child; 1980 Feb; 134(2):140-3. PubMed ID: 6243443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rickets with alopecia-remission following a course of 1-alpha-hydroxy vitamin D3 therapy.
    Manandhar DS; Sarkawi S; Hunt MC
    Eur J Pediatr; 1989 Aug; 148(8):761-3. PubMed ID: 2551693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease.
    Scriver CR; Reade TM; DeLuca HF; Hamstra AJ
    N Engl J Med; 1978 Nov; 299(18):976-9. PubMed ID: 308618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rickets with alopecia: an inborn error of vitamin D metabolism.
    Rosen JF; Fleischman AR; Finberg L; Hamstra A; DeLuca HF
    J Pediatr; 1979 May; 94(5):729-35. PubMed ID: 221630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.
    Balsan S; Garabedian M; Sorgniard R; Holick MF; Deluca HF
    Pediatr Res; 1975 Jul; 9(7):586-93. PubMed ID: 169507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D-deficiency in the elderly: treatment with ergocalciferol and hydroxylated analogues of vitamin D3.
    Shany S; Chaimovitz C; Yagev R; Bercovich M; Lowenthal MN
    Isr J Med Sci; 1988 Mar; 24(3):160-3. PubMed ID: 3259568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial hypophosphatemic rickets: a delineation of its subdivisions and pathogenesis.
    Walton J
    Clin Pediatr (Phila); 1976 Nov; 15(11):1007-12. PubMed ID: 184998
    [No Abstract]   [Full Text] [Related]  

  • 20. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.
    Hughes MR; Baylink DJ; Jones PG; Haussler MR
    J Clin Invest; 1976 Jul; 58(1):61-70. PubMed ID: 1084355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.